GoodRx Holdings, Inc. (GDRX) vs Harrow Health, Inc. (HROW)

A side-by-side comparison of GoodRx Holdings, Inc. and Harrow Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — GDRX vs HROW

growth of $100 · dividends reinvested · last 6y
GDRX -93.3% (-36.3%/yr)HROW +389.3% (+30.3%/yr)HROW compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $100202120222023202420252026$7$489
GDRX HROW

GDRX vs HROW: by the numbers

  • •GDRX is the larger company ($1.15B vs $1.13B market cap).
  • •GDRX is profitable (2.07% net margin) while HROW runs a net loss (-13.51%).
  • •HROW grew revenue faster over the past five years (34.52% vs 4.47% CAGR).

Metrics side by side

Valuation

MetricGDRXHROW
P/E ratio78.24N/A
P/S ratio1.474.11
P/B ratio1.7874.56
EV / EBITDA8.25N/A
FCF yield12.65%0.47%

Profitability

MetricGDRXHROW
Gross margin88.05%73.28%
Operating margin10.25%14.18%
Net margin2.07%-13.51%
ROE2.51%-244.91%
ROIC3.72%1.81%

Growth (annualized)

MetricGDRXHROW
Revenue CAGR (5Y)4.47%34.52%
FCF CAGR (5Y)11.72%N/A
Total return CAGR (5Y)-39.98%27.66%

Frequently asked

Which has grown faster, GDRX or HROW?
Over the past five years, HROW grew revenue faster — GDRX at a 4.47% CAGR versus HROW at 34.52%.
Is GDRX or HROW more profitable?
GDRX runs the higher net margin — GDRX at 2.07% versus HROW at -13.51%.
How have GDRX and HROW total returns compared?
Over the past 5 years, GDRX delivered -39.98% and HROW delivered 27.66% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.